Literature DB >> 19246615

Management of gene promoter mutations in molecular diagnostics.

Karen M K de Vooght1, Richard van Wijk, Wouter W van Solinge.   

Abstract

BACKGROUND: Although promoter mutations are known to cause functionally important consequences for gene expression, promoter analysis is not a regular part of DNA diagnostics. CONTENT: This review covers different important aspects of promoter mutation analysis and includes a proposed model procedure for studying promoter mutations. Characterization of a promoter sequence variation includes a comprehensive study of the literature and databases of human mutations and transcription factors. Phylogenetic footprinting is also used to evaluate the putative importance of the promoter region of interest. This in silico analysis is, in general, followed by in vitro functional assays, of which transient and stable transfection assays are considered the gold-standard methods. Electrophoretic mobility shift and supershift assays are used to identify trans-acting proteins that putatively interact with the promoter region of interest. Finally, chromatin immunoprecipitation assays are essential to confirm in vivo binding of these proteins to the promoter.
SUMMARY: Although promoter mutation analysis is complex, often laborious, and difficult to perform, it is an essential part of the diagnosis of disease-causing promoter mutations and improves our understanding of the role of transcriptional regulation in human disease. We recommend that routine laboratories and research groups specialized in gene promoter research cooperate to expand general knowledge and diagnosis of gene-promoter defects.

Entities:  

Mesh:

Year:  2009        PMID: 19246615     DOI: 10.1373/clinchem.2008.120931

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  23 in total

Review 1.  Cis-regulatory mutations in human disease.

Authors:  Douglas J Epstein
Journal:  Brief Funct Genomic Proteomic       Date:  2009-07-29

2.  Replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence creates murine model of major depressive disorder.

Authors:  George S Zubenko; Hugh B Hughes
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-05-19       Impact factor: 3.568

3.  Promoter Variant Alters Expression of the Autophagic BECN1 Gene: Implications for Clinical Manifestations of Machado-Joseph Disease.

Authors:  Nadiya Kazachkova; Mafalda Raposo; Amanda Ramos; Rafael Montiel; Manuela Lima
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

4.  A novel mutation in the promoter of RARS2 causes pontocerebellar hypoplasia in two siblings.

Authors:  Zejuan Li; Rhonda Schonberg; Lucia Guidugli; Amy Knight Johnson; Stephen Arnovitz; Sandra Yang; Joseph Scafidi; Marshall L Summar; Gilbert Vezina; Soma Das; Kimberly Chapman; Daniela del Gaudio
Journal:  J Hum Genet       Date:  2015-03-26       Impact factor: 3.172

5.  Cloning and ontogenetic expression of the uncoupling protein 1 gene UCP1 in sheep.

Authors:  Ya-Nan Yuan; Wen-Zhong Liu; Jian-Hua Liu; Li-Ying Qiao; Jian-Liang Wu
Journal:  J Appl Genet       Date:  2012-02-23       Impact factor: 3.240

6.  SIX1 gene: absence of mutations in children with isolated congenital anomalies of kidney and urinary tract.

Authors:  Susanna Negrisolo; Sonia Centi; Elisa Benetti; Giulia Ghirardo; Manuela Della Vella; Luisa Murer; Lina Artifoni
Journal:  J Nephrol       Date:  2014-06-05       Impact factor: 3.902

7.  PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing.

Authors:  Jennifer R Taube; Karen Sperle; Linda Banser; Pavel Seeman; Barbra Charina V Cavan; James Y Garbern; Grace M Hobson
Journal:  Hum Mol Genet       Date:  2014-06-01       Impact factor: 6.150

8.  An MTF1 binding site disrupted by a homozygous variant in the promoter of ATP7B likely causes Wilson Disease.

Authors:  Heidi I Chen; Karthik A Jagadeesh; Johannes Birgmeier; Aaron M Wenger; Harendra Guturu; Susan Schelley; Jonathan A Bernstein; Gill Bejerano
Journal:  Eur J Hum Genet       Date:  2018-08-07       Impact factor: 4.246

9.  Novel allelic variants in the canine cyclooxgenase-2 (Cox-2) promoter are associated with renal dysplasia in dogs.

Authors:  Mary H Whiteley; Jerold S Bell; Debby A Rothman
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

10.  Identification of cis-regulatory sequence variations in individual genome sequences.

Authors:  Rebecca Worsley-Hunt; Virginie Bernard; Wyeth W Wasserman
Journal:  Genome Med       Date:  2011-10-10       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.